38
Views
62
CrossRef citations to date
0
Altmetric
Original Article

Effects of Insulin-Like Growth Factors (IGFs) and IGF Receptor Antibodies on the Proliferation of Human Breast Cancer Cells

, , &
Pages 327-336 | Received 09 Jul 1991, Accepted 04 Dec 1991, Published online: 11 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

A. E. Richardson, N. Hamilton, W. Davis, C. Brito & D. De León. (2011) Insulin-like growth factor-2 (IGF-2) activates estrogen receptor-α and -β via the IGF-1 and the insulin receptors in breast cancer cells. Growth Factors 29:2-3, pages 82-93.
Read now
Michelle K. O'Han, Robert C. Baxter & Lynette J. Schedlich. (2009) Effects of endogenous insulin-like growth factor binding protein-3 on cell cycle regulation in breast cancer cells. Growth Factors 27:6, pages 394-408.
Read now
John SP Yuen & Valentine M Macaulay. (2008) Targeting the type 1 insulin-like growth factor receptor as a treatment for cancer. Expert Opinion on Therapeutic Targets 12:5, pages 589-603.
Read now
S. Kalla Singh, D. Moretta, F. Almaguel, M. De León & Daisy D. De León. (2008) Precursor Igf-ii (Proigf-ii) And Mature Igf-ii (Migf-ii) Induce Bcl-2 And Bcl-xl Expression Through Different Signaling Pathways In Breast Cancer Cells. Growth Factors 26:2, pages 92-103.
Read now

Articles from other publishers (57)

Anna M. Nia, Kamil Khanipov, Brooke L. Barnette, Robert L. Ullrich, George Golovko & Mark R. Emmett. (2020) Comparative RNA-Seq transcriptome analyses reveal dynamic time-dependent effects of 56Fe, 16O, and 28Si irradiation on the induction of murine hepatocellular carcinoma. BMC Genomics 21:1.
Crossref
Kamyar M. Hedayat & Jean-Claude Lapraz. 2019. The Theory of Endobiogeny. The Theory of Endobiogeny 267 283 .
Rafael Alvarez, Elika Ridelman, Natalie Rizk, Morgan S. White, Chuan Zhou, Heang-Ping Chan, Oliver A. Varban, Mark A. Helvie & Randy J. Seeley. (2018) Assessment of mammographic breast density after sleeve gastrectomy. Surgery for Obesity and Related Diseases 14:11, pages 1643-1651.
Crossref
David Austin, Nalo Hamilton, Yahya Elshimali, Richard Pietras, Yanyuan Wu & Jaydutt Vadgama. (2018) Estrogen receptor-beta is a potential target for triple negative breast cancer treatment. Oncotarget 9:74, pages 33912-33930.
Crossref
Nasreen A. Vohra, Swapnil D. Kachare, Paul Vos, Bruce F. Schroeder, Olga Schuth, Dylan Suttle, Timothy L. Fitzgerald, Jan H. Wong & Kathryn M. Verbanac. (2016) The Short-Term Effect of Weight Loss Surgery on Volumetric Breast Density and Fibroglandular Volume. Obesity Surgery 27:4, pages 1013-1023.
Crossref
Deeksha Vishwamitra, Suraj Konnath George, Ping Shi, Ahmed O. Kaseb & Hesham M. Amin. (2016) Type I insulin-like growth factor receptor signaling in hematological malignancies. Oncotarget 8:1, pages 1814-1844.
Crossref
Nalo Hamilton, Diana Márquez-Garbán, Vei Mah, Gowry Fernando, Yahya Elshimali, Hermes Garbán, David Elashoff, Jaydutt Vadgama, Lee Goodglick & Richard Pietras. (2015) Biologic Roles of Estrogen Receptor- β and Insulin-Like Growth Factor-2 in Triple-Negative Breast Cancer . BioMed Research International 2015, pages 1-15.
Crossref
Callum Livingstone. (2013) IGF2 and cancer. Endocrine-Related Cancer 20:6, pages R321-R339.
Crossref
Yousef Hawsawi, Reem El-Gendy, Christopher Twelves, Valerie Speirs & James Beattie. (2013) Insulin-like growth factor — Oestradiol crosstalk and mammary gland tumourigenesis. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1836:2, pages 345-353.
Crossref
Valentina Belardi, Emily J. Gallagher, Ruslan Novosyadlyy & Derek LeRoith. (2013) Insulin and IGFs in Obesity-Related Breast Cancer. Journal of Mammary Gland Biology and Neoplasia 18:3-4, pages 277-289.
Crossref
Chul-Hoon Sung, Hee-Jung Im, Nahee Park, Yeojung Kwon, Sangyun Shin, Dong-Jin Ye, Nam-Hyeon Cho, Young-Shin Park, Hyung-Kyoon Choi, Donghak Kim & Young-Jin Chun. (2013) Induction of steroid sulfatase expression in PC-3 human prostate cancer cells by insulin-like growth factor II. Toxicology Letters 223:2, pages 109-115.
Crossref
Amit Khatri, Richard C. Brundage, Jessica M. Hull, Brent W. Williams, Douglas Yee & Mark N. Kirstein. (2011) Pharmacodynamic Modeling of Sequence-Dependent Antitumor Activity of Insulin-like Growth Factor Blockade and Gemcitabine. The AAPS Journal 14:1, pages 1-9.
Crossref
Ralph Graeser, Patricia Vrignaud, Norbert Esser, Sarah Umber, Ute Zirrgiebel, Marielle Chiron, Christoph Schaechtele & Michael H.G. Kubbutat. (2012) Generation of a Conditionally Transformed Murine Embryonic Fibroblast Cell Line Using Doxycycline-Dependent IGF-1R Overexpression. SLAS Discovery 17:3, pages 339-349.
Crossref
Frans van Valen, Henning Harrer, Marc Hotfilder, Uta Dirksen, Thomas Pap, George Gosheger, Hans-Ulrich Humpf & Heribert Jürgens. (2012) A Novel Role of IGF1 in Apo2L/TRAIL-Mediated Apoptosis of Ewing Tumor Cells. Sarcoma 2012, pages 1-14.
Crossref
Claire M. Perks & Jeff M.P. Holly. (2011) Hormonal Mechanisms Underlying the Relationship Between Obesity and Breast Cancer. Endocrinology and Metabolism Clinics of North America 40:3, pages 485-507.
Crossref
Raissa Perrault, Brenda Wright, Benjamin Storie, Avril Hatherell & Peter Zahradka. (2011) Tyrosine kinase-independent activation of extracellular-regulated kinase (ERK) 1/2 by the insulin-like growth factor-1 receptor. Cellular Signalling 23:4, pages 739-746.
Crossref
S. Kalla Singh, Q.W. Tan, C. Brito, M. De León, C. Garberoglio & D. De León. (2010) Differential insulin-like growth factor II (IGF-II) expression: A potential role for breast cancer survival disparity. Growth Hormone & IGF Research 20:2, pages 162-170.
Crossref
Mei‐Hsuan Wu, Yu‐Ching Chou, Wan‐Yun Chou, Giu‐Cheng Hsu, Chi‐Hong Chu, Cheng‐Ping Yu, Jyh‐Cherng Yu & Chien‐An Sun. (2009) Relationships between critical period of estrogen exposure and circulating levels of insulin‐like growth factor‐I (IGF‐I) in breast cancer: evidence from a case‐control study. International Journal of Cancer 126:2, pages 508-514.
Crossref
Andrea E. Wahner Hendrickson, Paul Haluska, Paula A. Schneider, David A. Loegering, Kevin L. Peterson, Ricardo Attar, B. Douglas Smith, Charles Erlichman, Marco Gottardis, Judith E. Karp, Joan M. Carboni & Scott H. Kaufmann. (2009) Expression of Insulin Receptor Isoform A and Insulin-like Growth Factor-1 Receptor in Human Acute Myelogenous Leukemia: Effect of the Dual-Receptor Inhibitor BMS-536924 In vitro . Cancer Research 69:19, pages 7635-7643.
Crossref
Upender Velaparthi, Mark Wittman, Peiying Liu, Joan M. Carboni, Francis Y. Lee, Ricardo Attar, Praveen Balimane, Wendy Clarke, Michael W. Sinz, Warren Hurlburt, Karishma Patel, Lorell Discenza, Sean Kim, Marco Gottardis, Ann Greer, Aixin Li, Mark Saulnier, Zheng Yang, Kurt Zimmermann, George Trainor & Dolatrai Vyas. (2008) Discovery and Evaluation of 4-(2-(4-chloro-1 H -pyrazol-1-yl)ethylamino)-3-(6-(1-(3-fluoropropyl)piperidin-4-yl)-4-methyl-1 H -benzo[ d ]imidazol-2-yl)pyridin-2(1 H )-one (BMS-695735), an Orally Efficacious Inhibitor of Insulin-like Growth Factor-1 Receptor Kinase with Broad Spectrum in Vivo Antitumor Activity . Journal of Medicinal Chemistry 51:19, pages 5897-5900.
Crossref
Margit Pacher, Michael J. Seewald, Mario Mikula, Susanne Oehler, Maurice Mogg, Ursula Vinatzer, Andreas Eger, Norbert Schweifer, Roland Varecka, Wolfgang Sommergruber, Wolfgang Mikulits & Martin Schreiber. (2007) Impact of constitutive IGF1/IGF2 stimulation on the transcriptional program of human breast cancer cells. Carcinogenesis 28:1, pages 49-59.
Crossref
Yang Feng, Zhongyu Zhu, Xiaodong Xiao, Vidita Choudhry, J. Carl Barrett & Dimiter S. Dimitrov. (2006) Novel human monoclonal antibodies to insulin-like growth factor (IGF)-II that potently inhibit the IGF receptor type I signal transduction function. Molecular Cancer Therapeutics 5:1, pages 114-120.
Crossref
Sharda Vyas, Yayesh Asmerom & Daisy D. De León. (2005) Resveratrol Regulates Insulin-Like Growth Factor-II in Breast Cancer Cells. Endocrinology 146:10, pages 4224-4233.
Crossref
Joan M. Carboni, Adrian V. Lee, Darryl L. Hadsell, Bruce R. Rowley, Francis Y. Lee, David K. Bol, Amy E. Camuso, Marco Gottardis, Ann F. Greer, Ching Ping Ho, Warren Hurlburt, Aixin Li, Mark Saulnier, Upender Velaparthi, Cindy Wang, Mei-Li Wen, Richard A. Westhouse, Mark Wittman, Kurt Zimmermann, Brent A. Rupnow & Tai W. Wong. (2005) Tumor Development by Transgenic Expression of a Constitutively Active Insulin-Like Growth Factor I Receptor. Cancer Research 65:9, pages 3781-3787.
Crossref
Liliane Goetsch, Alexandra Gonzalez, Olivier Leger, Alain Beck, Petrus J. Pauwels, Jean François Haeuw & Nathalie Corvaia. (2004) A recombinant humanized anti‐insulin‐like growth factor receptor type I antibody (h7C10) enhances the antitumor activity of vinorelbine and anti‐epidermal growth factor receptor therapy against human cancer xenografts. International Journal of Cancer 113:2, pages 316-328.
Crossref
Carlos Garcı́a-Echeverrı́a, Mark A Pearson, Andreas Marti, Thomas Meyer, Juergen Mestan, Johann Zimmermann, Jiaping Gao, Josef Brueggen, Hans-Georg Capraro, Robert Cozens, Dean B Evans, Doriano Fabbro, Pascal Furet, Diana Graus Porta, Janis Liebetanz, Georg Martiny-Baron, Stephan Ruetz & Francesco Hofmann. (2004) In vivo antitumor activity of NVP-AEW541—A novel, potent, and selective inhibitor of the IGF-IR kinase. Cancer Cell 5:3, pages 231-239.
Crossref
Tawhid Ahmad, Gillian Farnie, Nigel J. Bundred & Neil G. Anderson. (2004) The Mitogenic Action of Insulin-like Growth Factor I in Normal Human Mammary Epithelial Cells Requires the Epidermal Growth Factor Receptor Tyrosine Kinase. Journal of Biological Chemistry 279:3, pages 1713-1719.
Crossref
Eva Surmacz. (2003) Growth factor receptors as therapeutic targets: strategies to inhibit the insulin-like growth factor I receptor. Oncogene 22:42, pages 6589-6597.
Crossref
Lital Keinan-Boker, H. Bas Bueno de Mesquita, Rudolf Kaaks, Carla H. van Gils, Paul A.H. van Noord, Sabina Rinaldi, Elio Riboli, Jaap C. Seidell, Diederick E. Grobbee & Petra H.M. Peeters. (2003) Circulating levels of insulin-like growth factor I, its binding proteins -1,-2, -3, C-peptide and risk of postmenopausal breast cancer. International Journal of Cancer 106:1, pages 90-95.
Crossref
Julie A Lovegrove. (2013) Obesity, body fat distribution and breast cancer. Nutrition Research Reviews 15:2, pages 389-412.
Crossref
Karen S. Strange, Darcy Wilkinson & Joanne T. Emerman. (2002) Mitogenic Properties of Insulin-Like Growth Factors I and II, Insulin-Like Growth Factor Binding Protein-3 and Epidermal Growth Factor on Human Breast Epithelial Cells in Primary Culture. Breast Cancer Research and Treatment 75:3, pages 203-212.
Crossref
Susan L Grant, Annet Hammacher, Andrea M Douglas, Geraldine A Goss, Rachel K Mansfield, John K Heath & C Glenn Begley. (2002) An unexpected biochemical and functional interaction between gp130 and the EGF receptor family in breast cancer cells. Oncogene 21:3, pages 460-474.
Crossref
Paolo Toniolo, Peter F. Bruning, Arslan Akhmedkhanov, Johannes M.G. Bonfrer, Karen L. Koenig, Annekatrin Lukanova, Roy E. Shore & Anne Zeleniuch-Jacquotte. (2000) Serum insulin-like growth factor-I and breast cancer. International Journal of Cancer 88:5, pages 828-832.
Crossref
C.A. Fowler, C.M. Perks, P.V. Newcomb, P.B. Savage, J.R. Farndon & J.M.P. Holly. (2000) Insulin-like growth factor binding protein-3 (IGFBP-3) potentiates paclitaxel-induced apoptosis in human breast cancer cells. International Journal of Cancer 88:3, pages 448-453.
Crossref
Hasnain M. Khandwala, Ian E. McCutcheon, Allan Flyvbjerg & Keith E. Friend. (2000) The Effects of Insulin-Like Growth Factors on Tumorigenesis and Neoplastic Growth. Endocrine Reviews 21:3, pages 215-244.
Crossref
Giuseppe Minniti & Youngman Oh. 2000. Endocrine Oncology. Endocrine Oncology 215 235 .
S.P Xie, G Pirianov & K.W Colston. (1999) Vitamin D analogues suppress IGF-I signalling and promote apoptosis in breast cancer cells. European Journal of Cancer 35:12, pages 1717-1723.
Crossref
Yoshitaka Yamanaka, John L. Fowlkes, Elizabeth M. Wilson, Ron G. Rosenfeld & Youngman Oh. (1999) Characterization of Insulin-Like Growth Factor Binding Protein-3 (IGFBP-3) Binding to Human Breast Cancer Cells: Kinetics of IGFBP-3 Binding and Identification of Receptor Binding Domain on the IGFBP-3 Molecule*. Endocrinology 140:3, pages 1319-1328.
Crossref
S. Peter Nissley. 1999. The IGF System. The IGF System 165 197 .
Paul Jenkins. (1998) Cancer in Acromegaly. Trends in Endocrinology & Metabolism 9:9, pages 360-366.
Crossref
D. Desaulniers, K. Leingartner, T. Zacharewski & W.G. Foster. (1998) Optimization of an MCF7-E3 Cell Proliferation Assay and Effects of Environmental Pollutants and Industrial Chemicals. Toxicology in Vitro 12:4, pages 409-422.
Crossref
John A. Thomas. (2016) Drugs and Chemicals that Affect the Endocrine System. International Journal of Toxicology 17:2, pages 129-138.
Crossref
Youngman Oh. (1998) Igf-independent regulation of breast cancer growth by IGF binding proteins. Breast Cancer Research and Treatment 47:3, pages 283-293.
Crossref
Daisy D. De leon & Sharon M. Donovan. (1997) Is breast cancer a potential side effect of GH treatment?. Nature Medicine 3:10, pages 1081-1082.
Crossref
Shunichi Yokoyama, Lucia Stefaneanu & Kalman Kovacs. (1997) Pituitary insulin-like growth factors. Endocrine Pathology 8:3, pages 167-179.
Crossref
J.L. Outwater, A. Nicholson & N. Barnard. (1997) Dairy products and breast cancer: the IGF-I, estrogen, and bGH hypothesis. Medical Hypotheses 48:6, pages 453-461.
Crossref
Kevin M. Kelley, Youngman Oh, Sharron E. Gargosky, Zoran Gucev, Tomoko Matsumoto, Vivian Hwa, Lilly Ng, Diane M. Simpson & Ron G. Rosenfeld. (1996) Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics. The International Journal of Biochemistry & Cell Biology 28:6, pages 619-637.
Crossref
Haim Werner & Derek LeRoith. 1996. 183 223 .
R.J. Holden. (1995) The estrogen connection: The etiological relationship between diabetes, cancer, rheumatoid arthritis and psychiatric disorders. Medical Hypotheses 45:2, pages 169-189.
Crossref
Peter F. Bruning, Jaap Van Doorn, Johannes M. G. Bonfrèr, Paul A. M. Van Noord, Catharina M. Korse, Theodora C. Linders & Augustinus A. M. Hart. (2006) Insulin‐like growth‐factor‐binding protein 3 is decreased in early‐stage operable pre‐menopausal breast cancer. International Journal of Cancer 62:3, pages 266-270.
Crossref
Youngman Oh, Hermann L. Müller, Lilly Ng & Ron G. Rosenfeld. (1995) Transforming Growth Factor- β-induced Cell Growth Inhibition in Human Breast Cancer Cells Is Mediated through Insulin-like Growth Factor-binding Protein-3 Action. Journal of Biological Chemistry 270:23, pages 13589-13592.
Crossref
C. Booth, G. S. Evans & C. S. Potten. (1995) Growth factor regulation of proliferation in primary cultures of small intestinal epithelium. In Vitro Cellular & Developmental Biology - Animal 31:3, pages 234-243.
Crossref
Youngman Oh, Zoran Gucev, Lilly Ng, Hermann L. Müller & Ron G. Rosenfeld. (1995) Antiproliferative actions of insulin-like growth factor binding protein (IGFBP)-3 in human breast cancer cells. Progress in Growth Factor Research 6:2-4, pages 503-512.
Crossref
Yoshihiro Konishi, Keikichi Takahashi, De-Hua Chui, Ron G. Rosenfeld, Masaru Himeno & Takeshi Tabira. (1994) Insulin-like growth factor II promotes in vitro cholinergic development of mouse septal neurons: comparison with the effects of insulin-like growth factor I. Brain Research 649:1-2, pages 53-61.
Crossref
Youngman Oh, Hermann L. Müller, Heping Zhang, Nicholas Ling & Ron G. Rosenfeld. 1993. Current Directions in Insulin-Like Growth Factor Research. Current Directions in Insulin-Like Growth Factor Research 41 54 .
Y Oh, H L Müller, H Pham & R G Rosenfeld. (1993) Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells.. Journal of Biological Chemistry 268:35, pages 26045-26048.
Crossref
Y. Oh, H.L. Müller, G. Lamson & R.G. Rosenfeld. (1993) Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition. Journal of Biological Chemistry 268:20, pages 14964-14971.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.